Author

Xuebei An

Observed name: X. An

Observed institutions: Cleveland Clinic, The University of Texas MD Anderson Cancer Center, Ascendis Pharma (Denmark), Dana-Farber Cancer Institute, Case Western Reserve University, Seagen (United States)

OpenAlex ID: A5008773419

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

2020 · Nancy U. Lin, Virginia Borges, et al. · Journal of Clinical Oncology · 544

Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial

2020 · Aliya A Khan, Mishaela R Rubin, et al. · Journal of Bone and Mineral Research · 114

Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial

2024 · Bart L Clarke, Aliya A Khan, et al. · The Journal of Clinical Endocrinology & Metabolism · 46

A simulation model of colorectal cancer surveillance and recurrence

2014 · Johnie Rose, Knut Magne Augestad, et al. · BMC Medical Informatics and Decision Making · 20

275O Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+ metastatic breast cancer (MBC) with and without brain metastases (BM)

2020 · V. Mueller, E. Paplomata, et al. · Annals of Oncology · 4

Abstract PD13-04: Impact of tucatinib on health-related quality of life in patients with HER2+ metastatic breast cancer with stable and active brain metastases

2021 · Andrew Wardley, Volkmar Mueller, et al. · Cancer Research · 3

OR23-05 Log-term Efficacy And Safety Of Transcon PTH In Adults With Hypoparathyroidism: 52-week Results From The Open-label Extension Of The Phase 3 Pathway Trial

2023 · Bart Clarke, Aliya Aziz Khan, et al. · Journal of the Endocrine Society · 2

Obstructive Sleep Apnea and Asthma Co-morbidities Are Independent Predictors of New Heart Failure and Atrial Fibrillation in Patients With Diabetes Mellitus and Preserved Ejection Fraction

2012 · Sinziana Seicean, Kazuaki Negishi, et al. · Journal of the American College of Cardiology · 2

53. Tucatinib Vs Placebo Added to Trastuzumab and Capecitabine for Patients With Previously Treated Her2+ Metastatic Breast Cancer (mbc) With Brain Metastases (bm) (her2climb)

2020 · Nancy Lin, Rashmi Murthy, et al. · Neuro-Oncology Advances · 1

SIFORM: shared informative factor models for integration of multi-platform bioinformatic data

2016 · Xuebei An, Jianhua Hu, et al. · Bioinformatics · 1

Abstract #1408044: Long-term Efficacy and Safety of TransCon PTH from Phase 2 PaTH Forward Trial in Adults with Chronic Hypoparathyroidism

2023 · Bart Clarke, Lorenz Hofbauer, et al. · Endocrine Practice

Integration of Multi-platform High-dimensional Omic Data

2016 · Xuebei An · Digital Commons-TMC (Texas Medical Center)

Investigating the Validity of Observational Study Based on Electronic Medical Records and the Effectiveness of Perioperative Beta-Adrenoceptor Therapy to Reduce Postoperative Cardiac Events in Patients Undergoing Major Non-Cardiac Surgery

2012 · Xuebei An · OhioLink ETD Center (Ohio Library and Information Network)

Works count: 13

Citation count: 737

H-index: 4

I10-index: 4